Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Neurosci ; 52: 20-30, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23085403

ABSTRACT

Adult neurogenesis relies on EGF and FGF receptor (EGFR/FGFR) function and endocannabinoid (eCB) signalling. Here we have used a neural stem cell (NSC) line to determine how these systems cooperate to regulate neurogenesis. The results show the EGFR to be solely responsible for maintaining PI3K activation explaining its dominant role in promoting NSC survival. The EGFR and FGFR synergistically regulate the ERK/MAPK pathway, and this explains the requirement for both for optimal cell proliferation. The eCB receptors did not contribute to activation of the PI3K or ERK/MAPK pathways, highlighting the importance of another major proliferation pathway. The EGFR plays the dominant role in maintaining the transcriptome, with significant changes in the expression of over 3500 transcripts seen within hours of inhibition or activation of this receptor. The FGFR has a more modest effect on transcription with evidence for nodal integration with EGFR signalling at the level of the ERK/MAPK pathway. A common set of transcripts are regulated by the CB1 and CB2 receptors, with cooperation between these receptors and the EGFR apparent in the regulation of a pool of transcripts, most likely representing signal integration downstream from an as yet to be identified node. Finally, a first level molecular analysis of the transcriptional response shows regulation of a number of key growth factors, growth factor receptors and GPCRs to be under the control of the EGFR.


Subject(s)
Endocannabinoids/metabolism , Epidermal Growth Factor/metabolism , Fibroblast Growth Factors/metabolism , Neural Stem Cells/metabolism , Neurogenesis/physiology , Signal Transduction/physiology , Adult Stem Cells/cytology , Adult Stem Cells/metabolism , Animals , Blotting, Western , Cell Line , Mice , Neural Stem Cells/cytology , Protein Array Analysis , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
2.
Philos Trans R Soc Lond B Biol Sci ; 367(1607): 3264-75, 2012 Dec 05.
Article in English | MEDLINE | ID: mdl-23108545

ABSTRACT

The diacylglycerol lipases (DAGLs) hydrolyse diacylglycerol to generate 2-arachidonoylglycerol (2-AG), the most abundant ligand for the CB(1) and CB(2) cannabinoid receptors in the body. DAGL-dependent endocannabinoid signalling regulates axonal growth and guidance during development, and is required for the generation and migration of new neurons in the adult brain. At developed synapses, 2-AG released from postsynaptic terminals acts back on presynaptic CB(1) receptors to inhibit the secretion of both excitatory and inhibitory neurotransmitters, with this DAGL-dependent synaptic plasticity operating throughout the nervous system. Importantly, the DAGLs have functions that do not involve cannabinoid receptors. For example, 2-AG is the precursor of arachidonic acid in a pathway that maintains the level of this essential lipid in the brain and other organs. This pathway also drives the cyclooxygenase-dependent generation of inflammatory prostaglandins in the brain, which has recently been implicated in the degeneration of dopaminergic neurons in Parkinson's disease. Remarkably, we still know very little about the mechanisms that regulate DAGL activity-however, key insights can be gleaned by homology modelling against other α/ß hydrolases and from a detailed examination of published proteomic studies and other databases. These identify a regulatory loop with a highly conserved signature motif, as well as phosphorylation and palmitoylation as post-translational mechanisms likely to regulate function.


Subject(s)
Endocannabinoids/metabolism , Lipoprotein Lipase/metabolism , Synaptic Transmission , Animals , Arachidonic Acid/metabolism , Arachidonic Acids/metabolism , Brain/enzymology , Brain/physiopathology , Catalytic Domain , Cloning, Molecular , Enzyme Activation , Enzyme Stability , Glycerides/metabolism , Humans , Lipoprotein Lipase/genetics , Mice , Neuronal Plasticity , Phosphorylation
3.
J Neurosci ; 30(6): 2017-24, 2010 Feb 10.
Article in English | MEDLINE | ID: mdl-20147530

ABSTRACT

Endocannabinoids (eCBs) function as retrograde signaling molecules at synapses throughout the brain, regulate axonal growth and guidance during development, and drive adult neurogenesis. There remains a lack of genetic evidence as to the identity of the enzyme(s) responsible for the synthesis of eCBs in the brain. Diacylglycerol lipase-alpha (DAGLalpha) and -beta (DAGLbeta) synthesize 2-arachidonoyl-glycerol (2-AG), the most abundant eCB in the brain. However, their respective contribution to this and to eCB signaling has not been tested. In the present study, we show approximately 80% reductions in 2-AG levels in the brain and spinal cord in DAGLalpha(-/-) mice and a 50% reduction in the brain in DAGLbeta(-/-) mice. In contrast, DAGLbeta plays a more important role than DAGLalpha in regulating 2-AG levels in the liver, with a 90% reduction seen in DAGLbeta(-/-) mice. Levels of arachidonic acid decrease in parallel with 2-AG, suggesting that DAGL activity controls the steady-state levels of both lipids. In the hippocampus, the postsynaptic release of an eCB results in the transient suppression of GABA-mediated transmission at inhibitory synapses; we now show that this form of synaptic plasticity is completely lost in DAGLalpha(-/-) animals and relatively unaffected in DAGLbeta(-/-) animals. Finally, we show that the control of adult neurogenesis in the hippocampus and subventricular zone is compromised in the DAGLalpha(-/-) and/or DAGLbeta(-/-) mice. These findings provide the first evidence that DAGLalpha is the major biosynthetic enzyme for 2-AG in the nervous system and reveal an essential role for this enzyme in regulating retrograde synaptic plasticity and adult neurogenesis.


Subject(s)
Brain/metabolism , Cannabinoid Receptor Modulators/physiology , Endocannabinoids , Lipoprotein Lipase/genetics , Animals , Arachidonic Acids/metabolism , Brain/cytology , Glycerides/metabolism , Hippocampus/cytology , Hippocampus/metabolism , Liver/metabolism , Mice , Mice, Knockout , Neurogenesis , Neuronal Plasticity , Signal Transduction , Spinal Cord/metabolism , Synapses/physiology
4.
J Neurosci Res ; 88(4): 735-45, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19798744

ABSTRACT

The diacylglycerol lipases (DAGLalpha and DAGLbeta) synthesize 2-arachidonoylglycerol (2-AG), a full agonist at cannabinoid receptors. Dynamic regulation of DAGL expression underpins its role in axonal growth and guidance during development, retrograde synaptic signalling at mature synapses, and maintenance of adult neurogenesis. We show here that DAGLalpha expression is dramatically down-regulated when neural stem (NS) cells are differentiated toward a gamma-aminobutyric acidergic neuronal phenotype. To understand how DAGLalpha expression might be controlled, we sought to identify the core promoter region and regulatory elements within it. The core promoter was identified and shown to contain both an enhancer and a suppressor region. Deletion analysis identified two elements, including a GC-box, that specifically promote expression in NS cells. Bioinformatic analysis identified three candidate transcription factors that might regulate DAGLalpha expression in NS cells by binding to the GC box; these were specificity protein 1 (Sp1), early growth response element 1 (EGR1), and zinc finger DNA-binding protein 89 (ZBP-89). However, Sp1 was the only factor that could bind to the GC-box. A specific mutation within the GC-box that inhibited Sp1 binding reduced DAGLalpha promoter activity in NS cells. Likewise, a dominant negative Sp1 was shown to bind to the GC-box and to suppress DAGLalpha promoter activity specifically in NS cells. Finally, like DAGLalpha, Sp1 was down-regulated during neuronal differentiation. A full characterization of the DAGLalpha promoter will help to elucidate the upstream pathways that regulate DAGLalpha expression in NS cells and their progeny.


Subject(s)
Cell Differentiation/physiology , Down-Regulation/physiology , Embryonic Stem Cells/physiology , Lipoprotein Lipase/metabolism , Transcription Factors/physiology , Animals , Cell Line, Transformed , Cerebral Cortex/cytology , Chlorocebus aethiops , Down-Regulation/drug effects , Electrophoretic Mobility Shift Assay/methods , Embryonic Stem Cells/drug effects , Epidermal Growth Factor/pharmacology , Fibroblast Growth Factor 2/pharmacology , Glial Fibrillary Acidic Protein/metabolism , Humans , Lipoprotein Lipase/genetics , Mice , Mutagenesis/genetics , Protein Binding , Time Factors , Transfection/methods , Tubulin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...